Cite
Pertussis, diphtheria, and tetanus antibodies seroprevalence in pregnant women and neonates, as a preliminary data for introduction of preconception or prenatal DTaP vaccination among Japanese society.
MLA
Tsurane, Kotoi, et al. “Pertussis, Diphtheria, and Tetanus Antibodies Seroprevalence in Pregnant Women and Neonates, as a Preliminary Data for Introduction of Preconception or Prenatal DTaP Vaccination among Japanese Society.” Vaccine, vol. 40, no. 49, Nov. 2022, pp. 7122–29. EBSCOhost, https://doi.org/10.1016/j.vaccine.2022.09.092.
APA
Tsurane, K., Umehara, N., Nakayama, T., Okada, K., Inoue, M., Ogawa, K., Sago, H., Miyasaka, N., & Yamaguchi, K. (2022). Pertussis, diphtheria, and tetanus antibodies seroprevalence in pregnant women and neonates, as a preliminary data for introduction of preconception or prenatal DTaP vaccination among Japanese society. Vaccine, 40(49), 7122–7129. https://doi.org/10.1016/j.vaccine.2022.09.092
Chicago
Tsurane, Kotoi, Nagayoshi Umehara, Tetsuo Nakayama, Kenji Okada, Momoko Inoue, Kohei Ogawa, Haruhiko Sago, Naoyuki Miyasaka, and Koushi Yamaguchi. 2022. “Pertussis, Diphtheria, and Tetanus Antibodies Seroprevalence in Pregnant Women and Neonates, as a Preliminary Data for Introduction of Preconception or Prenatal DTaP Vaccination among Japanese Society.” Vaccine 40 (49): 7122–29. doi:10.1016/j.vaccine.2022.09.092.